[Event Report] Health Policy Summit 2016
date : 3/3/2016
Leading the World: Japan’s approach to solving health issues


Session 1: Sustainability in Health Care
The Despite the economic slump and limited health care resources, health care needs and medical costs continue to rise. Methods allowing a balance to be struck between health care cost suppression and health care quality improvement initiatives will become an issue in the near future. Is it possible for innovation and sustainability to coexist amidst the everlasting invention of ground breaking new drugs and new health care technologies. As a first step into the topic of financial affairs, discussions were held focusing on ways to improve sustainability in health care.
Panelists
Hirotaka Unami
(Senior Director for Social Security Budget, Ministry of Finance)
(Managing Director, Chief Economist, Morgan Stanley MUFG Securities Co., Ltd.)
Moderator
(HGPI Senior Manager)





Session 2: Global Health – G7 Summit and beyond
In 2016, Japan is playing host to the G7 Summit and Health Ministers’ Meeting, giving Japan the opportunity to strengthen its role as a global health leader and significantly contribute to the improvement of health around the world. The meaning of global health, which up until now has been focused on development assistance, is currently changing. This session focused on the contributions Japan is expected to make and the benefits of these contributions to Japan’s future. Panelists and participants discussed human resource development and the disaster management frameworks required at a global level.
Kenji Shibuya
(Professor, Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo; President, Japan Institute for Global Health (JIGH))
Yasuhiro Suzuki
(Assistant Minister for Technical Affairs & Chief Global Health Officer, Ministry of Health, Labour and Welfare)
Yoshiharu Yoneyama
(Deputy Director General, and Group Director for Health 2, Human Development Department, Japan International Cooperation Agency (JICA))
Anne Smith
(Manager, Health and Global Policy Institute)





Session 3: The Future of Health Care
Due to the size of the challenges faced and the height of the hurdles that need to be overcome, discussions about health care policy tend to stop at merely pointing out that issues exist. The original purpose of health care was to bring about “bright, future-oriented stories” by ensuring health for the people and the creation of a strong foundation for society. This session saw deep discussions surrounding emerging resources and innovative ideas aimed at supporting health policy makers and stakeholders in the construction of a stronger and more optimistic health care system.
Seigo Izumo
(Senior Vice President, Global Head of Regenerative Medicine Unit and Head of Scientific Affairs in Japan at Takeda Pharmaceutical Company)
Tomiko Tawaragi
(Chief Safety Officer, Pharmaceuticals and Medical Devices Agency (PMDA))
Shinsuke Muto
(President of Tetsuyu Institute Medical Corporation, Japan; Executive Advisor for Information Policy, MHLW; Co-Founder & Medical Director (Admin), Tetsuyu Healthcare Holdings, Japan)
Moderator
Ryoji Noritake
(Fellow, Health and Global Policy Institute; Consultant, Project HOPE (U.S. based NGO)









Co-hosted by Global Health Innovative Technology Fund (GHIT Fund)
Special sponsorship from Miraca Holdings
Supported by Ministry of Health and Labour and Welfare, and Ministry of Foreign Affairs
With cooperation from National Graduate Institute for Policy Studies, Global Health Innovation Policy Program
(Photos by Kazunori Izawa )
Exhibition date:2016-02-27
Top Research & Recommendations Posts
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Building a Research and Development System Together With People Living with Dementia and Their Families to Drive Parallel Progress in Creating an Inclusive Society and Advancing R&D (April 25, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Recommendations] Recommendations for the G7 Hiroshima Summit in 2023 Necessary Actions for AMR Control, Starting with the Introduction of Pull Incentives (August 29, 2022)
- [Policy Recommendations] Recommendations for the G7 Hiroshima Summit by the C7 Global Health Working Group (April 20, 2023)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Policy Recommendations] Requests for the G7 Hiroshima Summit and Related Ministerial Meetings: Promoting Measures for Climate Change and Planetary Health That Keep Pace With the International Community (December 19, 2022)
- [Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)
Featured Posts
-
2023-05-12
[Event Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders’ Declaration (April 28, 2023)
-
2023-05-15
[Event Report] (Live Broadcasting) A Dementia Symposium Commemorating the G7 Health Ministers’ Meeting in Nagasaki “Collaboration in the International Community for Advancing Dementia Measures in a New Era” (May 14, 2023)
-
2023-05-18
[Event Report] A NAGASAKI Planetary Health Expert Meeting “From COP27 and COP15 to the G7 Hiroshima Summit: New Partnerships for Solving Climate, Environment, Biodiversity and Health Issues” (May 12, 2023)
-
2023-05-19
[RegistrationOpen] Health Policy Academy the 12th Session
-
2023-05-26
[Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)